home / stock / rhhvf / rhhvf news


RHHVF News and Press, Roche Holding Div Rts

Stock Information

Company Name: Roche Holding Div Rts
Stock Symbol: RHHVF
Market: OTC

Menu

RHHVF RHHVF Quote RHHVF Short RHHVF News RHHVF Articles RHHVF Message Board
Get RHHVF Alerts

News, Short Squeeze, Breakout and More Instantly...

RHHVF - Greenwich LifeSciences: Halting Of Breast Cancer Recurrence With GLSI-100

2024-06-26 14:05:02 ET Summary Greenwich LifeSciences, Inc. approaches enrollment completion for the phase 3 Flamingo-01 study, using GLSI-100 for the treatment of patients with HER2/neu positive breast cancer, with full enrollment expected by the end of 2024. A prior phase 2b stu...

RHHVF - Roche: Obesity Treatment's Promise Isn't Enough

2024-06-25 17:50:06 ET Summary Roche Holding AG stock has seen a 13% price rise in the past month following positive trial results for its obesity treatment. Weight management and associated diseases like diabetes have huge potential, as seen from the examples of Novo Nordisk and ...

RHHVF - More Of The Same Isn't Good Enough For Roche

2024-06-18 16:03:19 ET Summary Roche continues to face challenges tied to lackluster revenue and profit outlook, questionable pipeline, and an underperforming diagnostics business. Roche spends aggressively on its pipeline (R&D and M&A) and is more successful than peers in...

RHHVF - Novo Nordisk: Leading The Fight Against Diabetes And Obesity

2024-06-18 11:26:22 ET Summary Novo Nordisk is a growth stock that continues to pleasantly surprise me and investors with the pace of its development of product candidates for the treatment of endocrine diseases. The company's share price reflects optimism about its diabetes franc...

RHHVF - Disc Medicine: Hematological Disorders Treatment Advances With DISC-0974 Progress

2024-06-14 13:26:47 ET Summary Disc Medicine, Inc. released positive results from the phase 2 AURORA study, using bitopertin for the treatment of patients with EPP and XLP. Potential FDA feedback to initiate a pivotal study using bitopertin for the treatment of patients with EPP a...

RHHVF - Structure Therapeutics: Yet Another Potential GLP-1 Entrant

2024-06-14 10:24:55 ET Summary Structure Therapeutics Inc. shares surged over 50% on positive GSBR-1290 data, competing with other oral GLP-1R clinical rivals. However, GSBR-1290's efficacy at week 12 fell below Novo Nordisk's amycretin, but still competitive in the obesity treatm...

RHHVF - Harding Loevner International Developed Markets Equity Composite Q1 2024 Report

2024-05-29 10:30:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

RHHVF - Harding Loevner International Equity ADR Composite Q1 2024 Report

2024-05-29 10:30:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

RHHVF - Harding Loevner International Equity Composite Q1 2024 Report

2024-05-29 09:25:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

RHHVF - Parnassus Core Equity Fund Q1 2024 Investment Commentary

2024-05-26 04:30:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...

Next 10